AI therapeutics platform Deep Genomics snags $180m Series C
Toronto-based Deep Genomics, an artificial intelligence therapeutics company, has raised $180 million in Series C financing.
Toronto-based Deep Genomics, an artificial intelligence therapeutics company, has raised $180 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination